ArticleJournal of asthma and allergy2013

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model.

Stacey Ackerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.